The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of ...
Respiratory syncytial virus (RSV) was first identified as a cause of human infection more than six decades ago, after the virus was isolated from respiratory swabs from two children with outpatient ...
Some results have been hidden because they may be inaccessible to you